Propel Bio Management, LLC Applied Therapeutics Inc. Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q3 2024
A detailed history of Propel Bio Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 6,567,858 shares of APLT stock, worth $57.1 Million. This represents 32.38% of its overall portfolio holdings.
Number of Shares
6,567,858
Previous 6,567,858
-0.0%
Holding current value
$57.1 Million
Previous $30.7 Billion
82.01%
% of portfolio
32.38%
Previous 19.89%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$91.6 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$86.1 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$85.4 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$69.6 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$59.1 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $417M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...